lunes, 15 de julio de 2019

Pharmaceutical mergers and megamergers stifle innovation - STAT

Pharmaceutical mergers and megamergers stifle innovation - STAT

First Opinion

Pharmaceutical mergers and megamergers stifle innovation

By KATY MILANI


RUBY WALLAU FOR STAT
Pharmaceutical mergers and megamergers, like the AbbVie and Allergan deal, may be good for business, bit it isn't good for innovation — or consumers.

No hay comentarios: